Projects per year
Fingerprint
Dive into the research topics where Mark P. Schoenberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 4 Finished
-
Clinical Applications of Molecular Biology in Bladder Cancer
Schoenberg, M. M. P. (PI) & Schoenberg, M. P. (PI)
5/31/05 → 11/30/09
Project: Research project
-
High Throughput Genetic Analysis of Bladder Cancer
Sidransky, D. (PI), Chan, T. Y. (CoPI), Goodman, S. N. (CoPI), Mathies, R. A. (CoPI), Schoenberg, M. P. (CoPI), Schoenberg, M. P. (CoPI) & Westra, W. W. H. (CoPI)
1/5/99 → 7/31/11
Project: Research project
-
MICROSATELLITES AS MARKERS FOR BLADDER CANCER
Schoenberg, M. P. (PI)
10/1/98 → 9/30/02
Project: Research project
-
MOLECULAR PROGRESSION MODEL FOR TRANSITIONAL CELL CARCINOMA
Schoenberg, M. P. (PI), Westra, W. (PI), Goodman, S. (PI), Mathies, R. (PI), Chan, T. (PI), Sidransky, D. (PI), Goodman, S. (PI), Mathies, R. (PI) & Schoenberg, M. P. (PI)
1/1/01 → 7/31/11
Project: Research project
-
Adopting the Fruits of Innovation: Using New Drugs to Treat Nonmuscle-Invasive Bladder Cancer
Bivalacqua, T. J., Sankin, A. & Schoenberg, M., Mar 2026, In: Journal of Urology. 215, 3, p. 261-263 3 p.Research output: Contribution to journal › Editorial › peer-review
-
Reply by Authors
Prasad, S. M., Shishkov, D., Mihaylov, N. V., Genov, P., Terzi, V., Kates, M., Huang, W. C., Louie, M. J., Burger, B., Meads, A. & Schoenberg, M., Aug 1 2026, In: Journal of Urology.Research output: Contribution to journal › Letter › peer-review
-
Response to primary chemoablation with UGN-102 in different EOTRC risk groups.
ENVISION Study Group, Mar 2026, In: Journal of Clinical Oncology. 44, p. 733 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
UGN-102 for Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: 24-Month Duration of Response Results From the Phase 3 ENVISION Trial
on behalf of the ENVISION Study Group, Aug 2026, In: Journal of Urology. 216, 2, p. 194-205 12 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
Editorial Comment
Prasad, S. M. & Schoenberg, M., Feb 1 2025, In: Journal of Urology. 213, 2, p. 148-149 2 p.Research output: Contribution to journal › Comment/debate › peer-review